The shares in Arjo are distributed to the shareholders in Getinge and listed on Nasdaq Stockholm

Arjo AB (publ) (“Arjo”), the former Patient & Post-Acute Care business area of Getinge AB (“Getinge”), is now a separately listed company with its shares of series B trading on Nasdaq Stockholm.

On 12 December 2017, the shares of series B in Arjo were admitted to trading on Nasdaq Stockholm, following a distribution of the shares to the shareholders in Getinge. Following the resolution on distribution and the listing of Arjo, the Getinge Group is divided into two independent, listed companies, Arjo which consist of the former Patient & Post-Acute Care business area and the related area Flusher Disinfection and Getinge with the remaining business areas Surgical Workflows and Acute Cate Therapies. Following the split, both Getinge and Arjo are expected to have a more dedicated business focus, with more opportunities to continue to develop tailored products and solutions to meet the specific needs of their respective customers, where Arjo’s business is more patient focused.

Arjo is a global supplier of medical devices, services and solutions that improves the lives of people affected by reduced mobility and age-related health challenges. Arjo’s offering includes products and solutions within the areas of patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism prevention and diagnostics within obstetrics and cardiology. Arjo has over 5,900 employees worldwide and customers in over 60 countries. In 2016 the Arjo sales amounted to about SEK 8 billion.

Getinge and Arjo have been advised by Mannheimer Swartling throughout the separation, distribution and listing of Arjo.